ODESSA, FL, June 19, 2018 (GLOBE NEWSWIRE) -- Dais Analytic Corporation (OTCQB: DLYT ), a commercial nanotechnology materials business selling its industry-changing nanomaterial technology into the worldwide water, air and energy markets, announced growing sales orders for its proprietary nanotechnology polymer based materials and components.
The Company announced today it has secured new orders totaling approximately $330,000, which is consistent with previously disclosed increases in revenue expectations for the remainder of 2018.
The new orders include sales of nanomaterials and components for NanoClear™ industrial waste water treatment, and ConsERV™ for heating, ventilating, and air-conditioning (HVAC). Deliveries of the completed orders are expected to commence in the third quarter of 2018.
“We are pleased to announce the continued increase in sales for our innovative, state-of-the-art, proprietary products. These orders indicate a growing demand for benefits the products provide our customers, and assist Dais in meeting its revenue projections for the remainder of Fiscal 2018. As we expand our products into newer channels we remain optimistic about revenues accelerating in Fiscal 2019,” says Tim Tangredi, Dais’s CEO.
Dais projects it will continue to grow throughout 2018 as it sets its sights on a conventional capital raise and planned future up-listing to a national securities exchange such as the NASDAQ Capital Market.
About Dais Analytic Corporation
Dais Analytic Corporation (OTCQB: DLYT ) is a nanotechnology business producing a versatile family of membrane materials -- called Aqualyte™ -- focusing on evolutionary or disruptive air, energy and water applications. The uses include:
- NanoClear™, a commercialized system treating contaminated industrial waste water providing ultra-pure potable water with higher system efficiencies at equal or better capital and operating costs than other technologies.
- ConsERV™, a commercially available engineered energy recovery ventilator that uses stale air being exhausted to precondition the temperature and moisture content of the incoming fresh ventilation air, typically saving energy, reducing CO2 emissions, and allowing for equipment downsizing;
- PolyCool™, an Aqualyte™-based next generation evaporative cooling technology that is nearing full commercialization. Aqualyte is configured for use in cooling towers and evaporative condensers for cooling uses in traditional HVAC, waste water treatment, and power systems industries providing reduced energy and operating costs. Other key features include preventing release of dangerous microbes such as Legionella, and opening new markets for smaller air-cooled HVAC systems.
- NanoAir™, a water-based cooling cycle with no fluorocarbon refrigerants that is in early beta-stage testing which can replace existing vapor compression cooling cycles in most forms of air-conditioning and refrigeration, saving a projected 50% in energy and CO2.
Each use demonstrates the diversity of Dais' core product, Aqualyte™, a family of nanostructured polymers and engineered processes focused on minimizing consumption of irreplaceable natural resources and ending the degradation of our environment. To find out more about Dais please visit www.daisanalytic.com .
Safe Harbor Statement
This press release includes statements that may constitute forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," and similar statements. Statements that are not historical facts, including statements about the Company's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. For example, statements about future revenues and the Company’s ability to fund its operations and contractual obligations are forward looking and subject to risks. Several important factors could cause actual results to differ materially from those contained in any forward-looking statement. Potential risks and uncertainties include, but are not limited to, the inability to raise capital to support the Company through its growth stage, the Company’s inability to generate projected sales and trade relations between the United States and China. The Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
Peter Dichiara 212-658 0458
